| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Caissa Capital Management Ltd. is a 10% Owner at AVTX. Recent filings cover 34 purchases and 0 sales.
Our model assigns Caissa Capital Management Ltd. a below-average insider score of 22/100, based on 32 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -98.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 7,500 | $2.99 | $22,423.19 | +0.6% | -91.8% | -97.6% | |
| Apr 24, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 17,500 | $3.07 | $53,671.50 | +1.4% | -91.8% | -98.2% | |
| Apr 18, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 25,000 | $2.95 | $73,874.00 | +2.0% | -87.8% | -98.0% | |
| Apr 11, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 56,329 | $2.53 | $142,516.39 | +4.7% | -88.3% | -98.0% |